
Pfizer looking to become first company with approved COVID-19 vaccine for kids aged 5 to 11.
Pfizer has asked Health Canada to approve use of its vaccine on kids between the ages of 5 and 11.
If given the go-ahead, it'll be the first shot available to children in Canada, but new child-sized doses will need to be made available.
The vaccine was a team effort with Germany's BioNTech, and the doses are about one-third the size of that given to people 12 and older.
The company completed a clinical trial for its child-size dose, and the data was submitted to Health Canada earlier this month.
As well, a formal request for approval was made last week to the U.S. Food and Drug Administration.